Abstraction
Background: Total knee arthroplasty (TKA) was the procedure which is preform by orthopedic surgeons in end stage osteoarthritis knee patients who fail conservative treatment. Periarticular analgesia is one of the effective and safe technique used to reduce pain after surgery. However, the location and formula of the mixture have not yet been controversy. Recently, a study compared intraosseous analgesic injection, which provided significant postoperative pain relief compared to the control group. The authors conducted this study to compare periarticular and intraosseous analgesic injection in patients undergoing simultaneous bilateral total knee arthroplasty.
Method: The study is a two-arm, double-blinded, randomized controlled trial with 26 patients (52 knees) who underwent simultaneous bilateral total knee arthroplasty. The primary outcome is postoperative pain at 12, 24, and 48 hours using the Visual Analog Scale for assessment. The secondary outcomes include postoperative range of motion at 24 and 48 hours, postoperative blood loss, and postoperative complications.
Discussion: While periarticular analgesic is the standard practice, intraosseous analgesic injection is a potential route for controlling postoperative pain after total knee arthroplasty surgery. This study offers a better alternative route for analgesic injection.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
TCTR20230124001
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Rajavithi hospital ethics committee gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The authors received no specific funding for this work.
Data Availability
All data produced in the present study are available upon reasonable request to the authors